JP2024546107A5 - - Google Patents
Info
- Publication number
- JP2024546107A5 JP2024546107A5 JP2024534260A JP2024534260A JP2024546107A5 JP 2024546107 A5 JP2024546107 A5 JP 2024546107A5 JP 2024534260 A JP2024534260 A JP 2024534260A JP 2024534260 A JP2024534260 A JP 2024534260A JP 2024546107 A5 JP2024546107 A5 JP 2024546107A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- alkyl
- cyano
- occurrence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287866P | 2021-12-09 | 2021-12-09 | |
| US63/287,866 | 2021-12-09 | ||
| US202263393440P | 2022-07-29 | 2022-07-29 | |
| US63/393,440 | 2022-07-29 | ||
| PCT/US2022/081236 WO2023108103A1 (en) | 2021-12-09 | 2022-12-09 | Raf kinase inhibitors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546107A JP2024546107A (ja) | 2024-12-17 |
| JP2024546107A5 true JP2024546107A5 (cg-RX-API-DMAC7.html) | 2025-12-16 |
Family
ID=85018968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534260A Pending JP2024546107A (ja) | 2021-12-09 | 2022-12-09 | Rafキナーゼ阻害剤及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230357179A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4444430A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024546107A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119585242A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022405115A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3240192A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202342442A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023108103A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102708177B1 (ko) | 2018-01-31 | 2024-09-23 | 데시페라 파마슈티칼스, 엘엘씨. | 위장관 기질 종양의 치료를 위한 병용 요법 |
| US20250361234A1 (en) * | 2022-06-06 | 2025-11-27 | Nico Therapeutics, Inc. | Compounds, compositions, and methods |
| JP2026522350A (ja) * | 2023-06-13 | 2026-07-07 | デシフェラ・ファーマシューティカルズ,エルエルシー | 二重raf阻害剤及びチューブリン阻害剤及びその使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1505064A1 (en) * | 2003-08-05 | 2005-02-09 | Bayer HealthCare AG | 2-Aminopyrimidine derivatives |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| US8906944B2 (en) * | 2009-09-03 | 2014-12-09 | Allergan, Inc. | Compounds as tyrosine kinase modulators |
| AR090151A1 (es) | 2012-03-07 | 2014-10-22 | Lilly Co Eli | Compuestos inhibidores de raf |
| JP6636014B2 (ja) * | 2014-09-12 | 2020-01-29 | ノバルティス アーゲー | Rafキナーゼ阻害剤としての化合物および組成物 |
| JP2022525885A (ja) * | 2019-03-22 | 2022-05-20 | キネート バイオファーマ インク. | Rafキナーゼの阻害剤 |
| AU2020371727B2 (en) * | 2019-10-24 | 2026-01-22 | Pierre Fabre Medicament | Inhibitors of RAF kinases |
| WO2022060996A1 (en) * | 2020-09-18 | 2022-03-24 | Kinnate Biopharma Inc. | Inhibitors of raf kinases |
-
2022
- 2022-12-09 AU AU2022405115A patent/AU2022405115A1/en active Pending
- 2022-12-09 CA CA3240192A patent/CA3240192A1/en active Pending
- 2022-12-09 EP EP22847085.2A patent/EP4444430A1/en active Pending
- 2022-12-09 WO PCT/US2022/081236 patent/WO2023108103A1/en not_active Ceased
- 2022-12-09 TW TW111147359A patent/TW202342442A/zh unknown
- 2022-12-09 JP JP2024534260A patent/JP2024546107A/ja active Pending
- 2022-12-09 CN CN202280091224.0A patent/CN119585242A/zh active Pending
- 2022-12-09 US US18/078,269 patent/US20230357179A1/en active Pending